Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.

MLA

Vasseur, Antoine, et al. “Efficacy of Taxanes Rechallenge in First-Line Treatment of Early Metastatic Relapse of Patients with HER2-Negative Breast Cancer Previously Treated with a (Neo)Adjuvant Taxanes Regimen: A Multicentre Retrospective Observational Study.” Breast (Edinburgh, Scotland), vol. 65, Oct. 2022, pp. 136–44. EBSCOhost, https://doi.org/10.1016/j.breast.2022.07.014.

APA

Vasseur, A., Carton, M., Guiu, S., Augereau, P., Uwer, L., Mouret-Reynier, M.-A., Levy, C., Eymard, J.-C., Ferrero, J.-M., Leheurteur, M., Goncalves, A., Robert, M., De La Motte Rouge, T., Bachelot, T., Petit, T., Debled, M., Grinda, T., Desmoulins, I., Vanlemmens, L., … Cabel, L. (2022). Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study. Breast (Edinburgh, Scotland), 65, 136–144. https://doi.org/10.1016/j.breast.2022.07.014

Chicago

Vasseur, Antoine, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marie-Ange Mouret-Reynier, Christelle Levy, et al. 2022. “Efficacy of Taxanes Rechallenge in First-Line Treatment of Early Metastatic Relapse of Patients with HER2-Negative Breast Cancer Previously Treated with a (Neo)Adjuvant Taxanes Regimen: A Multicentre Retrospective Observational Study.” Breast (Edinburgh, Scotland) 65 (October): 136–44. doi:10.1016/j.breast.2022.07.014.